Saturday, 17 October 2026European Markets

KLAVENESS COMBINAT, AMSC, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(VIANEWS) - KLAVENESS COMBINAT (KCC.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Industrials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
KLAVENESS COMBINAT (KCC.OL) kr86.80 14.87% 23.47%
AMSC (AMSC.OL) kr26.50 12.8% 8.21%
MAREL (MAREL.AS) €3.13 0.5% 3.91%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. KLAVENESS COMBINAT (KCC.OL)

14.87% Forward Dividend Yield and 23.47% Return On Equity

Klaveness Combination Carriers ASA owns and operates combination carriers in Norway, the Far East, the Middle East/India, Australia, Brazil, Gulf Coast of the United States, and North America. Its vessels transport caustic coda solution or clean petroleum products, floating fertilizer, molasses, and various types of cargo, as well as petroleum products, heavy liquid cargoes, and various types of dry bulk products, such as alumina, bauxite, Iron ore, salt, grains, and coal. The company was incorporated in 2018 and is headquartered in Oslo, Norway. Klaveness Combination Carriers ASA is a subsidiary of Rederiaksjeselskapet Torvald Klaveness.

Earnings Per Share

As for profitability, KLAVENESS COMBINAT has a trailing twelve months EPS of kr14.28.

PE Ratio

KLAVENESS COMBINAT has a trailing twelve months price to earnings ratio of 6.08. Meaning, the purchaser of the share is investing kr6.08 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.47%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 14.8%, now sitting on 283.26M for the twelve trailing months.

More news about KLAVENESS COMBINAT.

2. AMSC (AMSC.OL)

12.8% Forward Dividend Yield and 8.21% Return On Equity

AMSC ASA, through its subsidiaries, operates as a ship owning and lease finance company in the United States. The company purchases and bareboat charters out vessels to operators and end users. It operates a fleet of nine product tankers, one shuttle tanker, and one subsea construction vessel. The company was formerly known as American Shipping Company ASA and changed its name to AMSC ASA in October 2022. AMSC ASA was founded in 2005 and is headquartered in Lysaker, Norway.

Earnings Per Share

As for profitability, AMSC has a trailing twelve months EPS of kr4.24.

PE Ratio

AMSC has a trailing twelve months price to earnings ratio of 6.25. Meaning, the purchaser of the share is investing kr6.25 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.21%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 39.6%, now sitting on 102.25M for the twelve trailing months.

More news about AMSC.

3. MAREL (MAREL.AS)

0.5% Forward Dividend Yield and 3.91% Return On Equity

Marel hf. develops, distributes, and sells solutions, software, and services to food processing industries in Europe, the Middle East, Africa, the Americas, Asia, and Oceania. The company's Poultry Processing segment offers integrated systems, software, and services for processing broilers, turkeys, and ducks. Its Meat Processing segment supplies primary, secondary, and further processing equipment, systems, software, and services of pork, beef, veal, and sheep. The company's Fish Processing segment offers equipment, systems, software, and services for farmed and wild salmon and whitefish processing. Its Plant, pet and feed segment provides solutions and services to the pet food, plant-based protein, and aqua feed markets. Marel hf. was founded in 1977 and is based in Garðabær, Iceland.

Earnings Per Share

As for profitability, MAREL has a trailing twelve months EPS of €0.05.

PE Ratio

MAREL has a trailing twelve months price to earnings ratio of 62.6. Meaning, the purchaser of the share is investing €62.6 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.91%.

Volatility

MAREL's last week, last month's, and last quarter's current intraday variation average was 0.57%, 0.70%, and 3.03%.

MAREL's highest amplitude of average volatility was 1.37% (last week), 2.50% (last month), and 3.03% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.4%, now sitting on 1.76B for the twelve trailing months.

Volume

Today's last reported volume for MAREL is 86259 which is 54.64% below its average volume of 190183.

Moving Average

MAREL's worth is way higher than its 50-day moving average of €2.64 and above its 200-day moving average of €3.02.

More news about MAREL.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com